Shorter sleep duration may raise the risk for glaucoma and elevated IOP in patients with obstructive sleep apnea.

For the 2025-2026 respiratory viral season, Moderna intends to have mResvia available for both FDA-approved patient populations.

Counseling was the most common smoking cessation service at US behavioral health centers in 2023, and pharmacotherapy was offered at less than half.

A magnesium depletion score of 1 or above indicated a 64% likelihood that an individual would develop OSA. Magnesium depletion is very likely an independent risk factor for obstructive sleep apnea ...

A multicancer early detection test may be able to detect circulating tumor DNA more than 3 years before diagnosis.

Women aged 40 years and older have a 50% greater risk for chronic obstructive pulmonary disease (COPD) vs men in the same age group, according to study findings published in BMJ Open Respiratory ...

The ACIP is recommending the use of Enflonsia for the prevention of RSV lower respiratory tract disease in infants younger than 8 months.

In smokers with COPD, LABA+LAMA is more effective than LABA+ICS in preventing exacerbations, regardless of blood eosinophil count.

This updated asthma guideline establishes a consistent approach to improving asthma diagnosis and control in adults and ...

Targeted therapies and immunotherapy can provide benefits when added to chemotherapy or may eliminate the need for ...

Regardless of chronic obstructive pulmonary disease status, finerenone mitigates clinical events and symptoms in patients with HFmrEF or HFpEF.

Health insurance companies have pledged to reduce prior authorization wait times, under pressure from the current administration.